213 related articles for article (PubMed ID: 27075580)
1. Virtual Screening Techniques and Current Computational Infrastructures.
Haga JH; Ichikawa K; Date S
Curr Pharm Des; 2016; 22(23):3576-84. PubMed ID: 27075580
[TBL] [Abstract][Full Text] [Related]
2. Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations.
Cournia Z; Allen B; Sherman W
J Chem Inf Model; 2017 Dec; 57(12):2911-2937. PubMed ID: 29243483
[TBL] [Abstract][Full Text] [Related]
3. In silico drug discovery approaches on grid computing infrastructures.
Wolf A; Shahid M; Kasam V; Ziegler W; Hofmann-Apitius M
Curr Clin Pharmacol; 2010 Feb; 5(1):37-46. PubMed ID: 19642967
[TBL] [Abstract][Full Text] [Related]
4. Function and structure-based screening of compounds, peptides and proteins to identify drug candidates.
Malik V; Dhanjal JK; Kumari A; Radhakrishnan N; Singh K; Sundar D
Methods; 2017 Dec; 131():10-21. PubMed ID: 28843611
[TBL] [Abstract][Full Text] [Related]
5. Deep Learning in Virtual Screening: Recent Applications and Developments.
Kimber TB; Chen Y; Volkamer A
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922714
[TBL] [Abstract][Full Text] [Related]
6. Virtual Screening Approaches towards the Discovery of Toll-Like Receptor Modulators.
Pérez-Regidor L; Zarioh M; Ortega L; Martín-Santamaría S
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618029
[TBL] [Abstract][Full Text] [Related]
7. From bench to bedside, via desktop. Recent advances in the application of cutting-edge in silico tools in the research of drugs targeting bromodomain modules.
Myrianthopoulos V; Mikros E
Biochem Pharmacol; 2019 Jan; 159():40-51. PubMed ID: 30414936
[TBL] [Abstract][Full Text] [Related]
8. VSpipe, an Integrated Resource for Virtual Screening and Hit Selection: Applications to Protein Tyrosine Phospahatase Inhibition.
Álvarez-Carretero S; Pavlopoulou N; Adams J; Gilsenan J; Tabernero L
Molecules; 2018 Feb; 23(2):. PubMed ID: 29414924
[TBL] [Abstract][Full Text] [Related]
9. Computational Toxicology Methods in Chemical Library Design and High-Throughput Screening Hit Validation.
Hevener KE
Methods Mol Biol; 2018; 1800():275-285. PubMed ID: 29934898
[TBL] [Abstract][Full Text] [Related]
10. Chemical Structure Similarity Search for Ligand-based Virtual Screening: Methods and Computational Resources.
Yan X; Liao C; Liu Z; Hagler AT; Gu Q; Xu J
Curr Drug Targets; 2016; 17(14):1580-1585. PubMed ID: 26521773
[TBL] [Abstract][Full Text] [Related]
11. Role of computer-aided drug design in modern drug discovery.
Macalino SJ; Gosu V; Hong S; Choi S
Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
[TBL] [Abstract][Full Text] [Related]
12. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
Zhang X; Wong SE; Lightstone FC
J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
[TBL] [Abstract][Full Text] [Related]
13. Optimization methods for virtual screening on novel computational architectures.
Pérez-Sánchez H; Wenzel W
Curr Comput Aided Drug Des; 2011 Mar; 7(1):44-52. PubMed ID: 20883205
[TBL] [Abstract][Full Text] [Related]
14. Combating Diseases with Computational Strategies Used for Drug Design and Discovery.
Makhouri FR; Ghasemi JB
Curr Top Med Chem; 2018; 18(32):2743-2773. PubMed ID: 30663568
[TBL] [Abstract][Full Text] [Related]
15. Fragment-based drug discovery and molecular docking in drug design.
Wang T; Wu MB; Chen ZJ; Chen H; Lin JP; Yang LR
Curr Pharm Biotechnol; 2015; 16(1):11-25. PubMed ID: 25420726
[TBL] [Abstract][Full Text] [Related]
16. Structure-Based Drug Discovery Accelerated by Many-Core Devices.
Feinstein W; Brylinski M
Curr Drug Targets; 2016; 17(14):1595-1609. PubMed ID: 26758669
[TBL] [Abstract][Full Text] [Related]
17. 3D bioprinting for drug discovery and development in pharmaceutics.
Peng W; Datta P; Ayan B; Ozbolat V; Sosnoski D; Ozbolat IT
Acta Biomater; 2017 Jul; 57():26-46. PubMed ID: 28501712
[TBL] [Abstract][Full Text] [Related]
18. How far can virtual screening take us in drug discovery?
Kar S; Roy K
Expert Opin Drug Discov; 2013 Mar; 8(3):245-61. PubMed ID: 23330660
[TBL] [Abstract][Full Text] [Related]
19. Fragment-based lead discovery on G-protein-coupled receptors.
Visegrády A; Keserű GM
Expert Opin Drug Discov; 2013 Jul; 8(7):811-20. PubMed ID: 23621346
[TBL] [Abstract][Full Text] [Related]
20. State-of-the-art in ligand-based virtual screening.
Ripphausen P; Nisius B; Bajorath J
Drug Discov Today; 2011 May; 16(9-10):372-6. PubMed ID: 21349346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
